Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 694

Response by Amgen Inc. to Roche's Rule 56.1 Statement in Opposition to Amgen's Motion for Summary Judgment that Dr. Lin's Asserted Claims Are Definite, Adequately Described and Enabled. (Gottfried, Michael)

Download PDF
Amgen Inc. v. F. Hoffmann-LaRoche LTD et al Doc. 694 Case 1:05-cv-12237-WGY Document 694 Filed 07/12/2007 Page 1 of 4 UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS ) ) ) Plaintiff, ) ) v. ) ) ) F. HOFFMANN-LA ROCHE ) LTD., a Swiss Company, ROCHE ) DIAGNOSTICS GmbH, a German ) Company and HOFFMANN-LA ROCHE ) INC., a New Jersey Corporation, ) ) Defendants. ) __________________________________________) AMGEN INC., Civil Action No.: 05-12237 WGY AMGEN INC.'S RESPONSE TO ROCHE'S RULE 56.1 STATEMENT IN OPPOSITION TO AMGEN'S MOTION FOR SUMMARY JUDGMENT THAT DR. LIN'S ASSERTED CLAIMS ARE DEFINITE, ADEQUATELY DESCRIBED AND ENABLED Amgen provides the following response to Roche's Rule 56.1 Statement in Opposition to Amgen's Motion for Summary Judgment and corresponding Rule 56.1 Statement filed in support thereof. 1. Regarding Roche's responses to Amgen's Rule 56.1 Statement, Amgen notes that in response to the facts set forth at ¶¶ 9 and 10 of Amgen's Statement, Roche objects on the grounds that the cited information or documents were not previously produced by Amgen. The information in ¶ 9 is publicly available from the USPTO.gov website and the document cited in ¶ 10 is a Roche patent available on the same website. As such, Amgen does not understand the basis for Roche's complaint. 2. Regarding the additional facts offered by Roche (at paragraphs 25-95 of Roche's Rule 56.1 Statement), the vast majority of the facts alleged are duplicative of statements previously set forth in Roche's Rule 56.1 Statements in support of its various motions for 732108_1 Dockets.Justia.com Case 1:05-cv-12237-WGY Document 694 Filed 07/12/2007 Page 2 of 4 summary judgment seeking to invalidate the claims-at-issue under 35 U.S.C. § 112. In response to such alleged facts, Amgen incorporates by reference its Rule 56.1 Statements, filed in support of its oppositions to such motions. These Statements are set forth at Docket Nos. 566, 581, and 629. In addition, Amgen incorporates by reference the Rule 56.1 Statement that will be filed on July 13, 2007 in response to Roche's July 3, 2007 Motion for Summary Judgment that `422 Claim 1 is Invalid Under § 112. The Rule 56.1 Statement for that motion recites the facts alleged at ¶¶ 25-26 and 28-31 of Roche's Rule 56.1 Statement herein at issue. 3. For the remaining facts (the facts alleged at paragraphs 27, 63-64, and 65-70), Amgen responds: · As to paragraph 27, Amgen contests the statement of fact contained in Roche's Facts paragraph 27 because the statement is imprecise as to which claims and limitations it refers and discounts that certain limitations can denote a structural limitation. Docket No. 613 at 18. · As to paragraphs 63-64, Amgen contests the statements of fact contained in Roche's Facts paragraphs 63-64 because they are inconsistent with other facts alleged by Roche in support of its other motions for summary judgment. See Docket No. 539 (arguing that Amgen has failed to prove that Roche's CHO cells produced the requisite level of EPO on the ground that, inter alia, Amgen failed to use the specific set of conditions used in Roche's commercial process); Docket No.568 at 6, n. 4 (arguing that `349 claim 7 requires some baseline level of production). · As to paragraphs 65-70, Amgen incorporates by reference its Rule 56.1 Statement, to be filed on July 13, in response to Roche's two July 3, 2007 Motions for Summary Judgment of Estoppel. 732108_1 2 Case 1:05-cv-12237-WGY Document 694 Filed 07/12/2007 Page 3 of 4 Dated: July 12, 2007 Respectfully Submitted, AMGEN INC., By its attorneys, Of Counsel: STUART L. WATT WENDY A. WHITEFORD MONIQUE L. CORDRAY DARRELL G. DOTSON KIMBERLIN L. MORLEY ERICA S. OLSON AMGEN INC. One Amgen Center Drive Thousand Oaks, CA 91320-1789 (805) 447-5000 _/s/ Michael R. Gottfried____________________ D.DENNIS ALLEGRETTI (BBO#545511) MICHAEL R.GOTTFRIED (BBO#542156)\ PATRICIA R. RICH (BBO#640578) DUANE MORRIS LLP 470 Atlantic Avenue, Suite 500 Boston, MA 02210 Telephone: (857) 488-4200 Facsimile: (857) 488-4201 LLOYD R. DAY, JR (pro hac vice) DAY CASEBEER MADRID & BATCHELDER LLP 20300 Stevens Creek Boulevard, Suite 400 Cupertino, CA 95014 Telephone: (408) 873-0110 Facsimile: (408) 873-0220 WILLIAM GAEDE III (pro hac vice) McDERMOTT WILL & EMERY 3150 Porter Drive Palo Alto, CA 94304 Telephone: (650) 813-5000 Facsimile: (650) 813-5100 KEVIN M. FLOWERS (pro hac vice) MARSHALL, GERSTEIN & BORUN LLP 233 South Wacker Drive 6300 Sears Tower Chicago IL 60606 Telephone: (312) 474-6300 Facsimile: (312) 474-0448 732108_1 3 Case 1:05-cv-12237-WGY Document 694 Filed 07/12/2007 Page 4 of 4 CERTIFICATE OF SERVICE I hereby certify that this document, filed through the ECF system will be sent electronically to the registered participants as identified on the Notice of electronic filing and paper copies will be sent to those indicated as non-registered participants. /s/ Michael R. Gottfried Michael R. Gottfried 732108_1 4

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?